Correlation Between OMX Stockholm and Vicore Pharma

Specify exactly 2 symbols:

Can any of the company-specific risk be diversified away by investing in both OMX Stockholm and Vicore Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OMX Stockholm and Vicore Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between OMX Stockholm Mid and Vicore Pharma Holding, you can compare the effects of market volatilities on OMX Stockholm and Vicore Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OMX Stockholm with a short position of Vicore Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of OMX Stockholm and Vicore Pharma.

Diversification Opportunities for OMX Stockholm and Vicore Pharma

0.17

Correlation Coefficient

OMX Stockholm

Vicore Pharma

Average diversification

The 3 months correlation between OMX and Vicore is 0.17. Overlapping area represents the amount of risk that can be diversified away by holding OMX Stockholm Mid and Vicore Pharma Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vicore Pharma Holding and OMX Stockholm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OMX Stockholm Mid are associated (or correlated) with Vicore Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vicore Pharma Holding has no effect on the direction of OMX Stockholm i.e., OMX Stockholm and Vicore Pharma go up and down completely randomly.

Optimize

Pair Corralation between OMX Stockholm and Vicore Pharma

Assuming the 90 days trading horizon OMX Stockholm Mid is expected to generate 0.44 times more return on investment than Vicore Pharma. However, OMX Stockholm Mid is 2.27 times less risky than Vicore Pharma. It trades about -0.25 of its potential returns per unit of risk. Vicore Pharma Holding is currently generating about -0.15 per unit of risk. If you would invest 167,920 in OMX Stockholm Mid on August 29, 2024 and sell it today you would lose (7,245) from holding OMX Stockholm Mid or give up 4.31% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

OMX Stockholm Mid vs. Vicore Pharma Holding

Performance

Timeline

OMX Stockholm and Vicore Pharma Volatility Contrast

Predicted Return Density

Returns

OMX Stockholm Mid

Pair trading matchups for OMX Stockholm

	OMX Stockholm vs. Svenska Handelsbanken AB
	OMX Stockholm vs. FormPipe Software AB
	OMX Stockholm vs. Skandinaviska Enskilda Banken
	OMX Stockholm vs. Online Brands Nordic

Vicore Pharma Holding

Pair trading matchups for Vicore Pharma

	Vicore Pharma vs. Hansa Biopharma AB
	Vicore Pharma vs. Xbrane Biopharma AB
	Vicore Pharma vs. BioArctic AB

Pair Trading with OMX Stockholm and Vicore Pharma

The main advantage of trading using opposite OMX Stockholm and Vicore Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OMX Stockholm position performs unexpectedly, Vicore Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vicore Pharma will offset losses from the drop in Vicore Pharma's long position.

	OMX Stockholm vs. Svenska Handelsbanken AB
	OMX Stockholm vs. FormPipe Software AB
	OMX Stockholm vs. Skandinaviska Enskilda Banken
	OMX Stockholm vs. Online Brands Nordic

The idea behind OMX Stockholm Mid and Vicore Pharma Holding pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

	Vicore Pharma vs. Hansa Biopharma AB
	Vicore Pharma vs. Xbrane Biopharma AB
	Vicore Pharma vs. BioArctic AB

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Other Complementary Tools

	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC